Article
An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.
British journal of clinical pharmacology - 1 Oct 1995
Halliday R C, Jones B C, Smith D A, Kitteringham N R, Park B K
Abstract excerpt
1. We have assessed the interaction of the antimalarial halofantrine with cytochrome P450 (CYP) enzymes in vitro, with the use of microsomes from human liver and recombinant cell lines. 2. Rac-halofantrine was a potent inhibitor (IC50 = 1.06 microM, Ki = 4.3 microM) of the 1-hydroxylation of bufu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
